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Many native proteins possess limited functionality, and modi-
fication such as succinylation is often performed to expand the
range of functional properties available for pharmaceutical
dosage form. Succinylation could be useful for modulating
protein-based system swelling and drug delivery properties es-
pecially for sustained controlled release dosage form like
microsphere. A well designed controlled drug delivery system
can overcome the problems of conventional drug therapy and
gives better therapeutic efficacy of a drug. Microspheres are
also undersigned as novel controlled drug delivery systems
having particle size less than 200 μm.
The aim of this research was succinylated soybean protein
(SSP) that could be used as excipient matrix for sustained
release microspheres containing propranolol hydrochloride as
a model active pharmaceutical ingredient.
Soy protein chemical modification was carried out as follows.
Soy concentrated protein was dispersed in distilled water for
2 h at a concentration of 5% w/v, and stirred 2 hours with a
speed of 1000 rpm. After dissolved succinic anhydride at
concentration 100% w/v in ethanol 96% was added gradually
to the soy concentrated protein with constant stirring and the
pH was maintained between 8 and 8.5 with 5 N NaOH.The re-
action was completed when the pH of the protein solution
stabilized. Excess Succinic anhydride was removed with ethanol
96%, and suspension of soy protein succinate was neutral-
ized with HCl 0.5 N then dried in an oven at 40–45 °C. Percentage
yield of succinylated soybean protein produced was 72,14%.
After that the product was analyzed included; degree of
succinylation, data of chemical interaction between soybean
protein and succinic anhydride analyzed by FTIR spectros-
copy, solubility index in aqueous medium at pH 1.2 and pH 7.5,
swelling index. Succinylated soybean protein was used asmatrix
in formula microsphere with propanolol HCl as a model active
pharmaceutical ingredient.
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Succinylated soybean protein produced is slightly yellow
colored, tasteless powder, and Chunk of irregular particle mor-
phology.The degree of substitution (DS) of Succinylated soybean
protein is 35,74 ± 0,38%. Chemical interaction showed peak in
wave at numbers 1653 cm−1 on IR spectrum which is indicat-
ing formed amide carbonyl group; has solubility index
0,21 ± 0,010 gram/100 ml in distilled water at pH 1,2 and
0,35 ± 0,003 gram/100 ml and pH 7,5. Succinylated soybean
protein product has swelling index 33,21 ± 2,04% at pH 1,2 and
66,36 ± 2,12% at pH 7,5, and water content in the powder 5,9%.
Sustained releasemicrospheres of propanolol HCl weremade
three formulas by using spray dryer method.The microspheres
have particle size diameters range 11,54–16,79 μm, yield values
36,46–58,91%, and encapsulation efficiency values 95,75–
99,81%. The composition of the formula 1 is 0,5% propanolol
HCl: 2% Succinylated soybean protein, for formula two 1,0%
propanolol HCl: 2% Succinylated soybean protein and formula
three 0,5% propanolol HCl: 2% soybean protein. Formulations
F1, F2 and F3 were taken into consideration for in vitro release
studies. In vitro release studies were carried out in HCl pH 1,2
and phosphate buffer pH 7,4 for a period of 12 h.
Characteristics of microspheres of propanolol HCl have par-
ticle size distribution based on diameter volume of formula 1,
2, 3 (11,54 μm, 14,70 μm, 16,79 μm). Entrapment efficiency of
propanolol HCl intomicrospheresmatrix excipient were formula
1 (99,81 ± 1,95%), formula 2 (92,65 ± 1,32%) and formula 3
(95,75 ± 1,80%). Swelling index of microsphere for 12 hours at
pH 1,2 and pH 7,5 were formula 1 (13,17 ± 4,18%; 15,15 ± 2,62%),
formula 2 (11,12 ± 6,45%; 30,46 ± 3,04%) and formula 3
(43,96 ± 7,39%; 5,12 ± 4,44%).
In vitro drug release profile showed that the cumulative
percent release was found to be 81,58 ± 3,04%, 63,05 ± 0,04%,
and 61,11 ± 1,58 for formulation F1, F2, and F3 respectively.We
conclude that these studies indicated that succinylated soybean
protein can be used as excipient for matrix sustained release
microspheres. The release rate of propanolol HCl (drug) from
the microspheres could be properly controlled for about 24 h.
Appropriate variation in the proportions of drug and excipi-
ent for matrix microsphere can lead to a product with the
desired controlled release features.
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